You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
|
|---|---|
| Published in |
Journal of Clinical Oncology, August 2014
|
| DOI | 10.1200/jco.2014.56.2025 |
| Pubmed ID | |
| Authors |
James N Kochenderfer, Mark E Dudley, Sadik H Kassim, Robert P T Somerville, Robert O Carpenter, Maryalice Stetler-Stevenson, James C Yang, Giao Q Phan, Marybeth S Hughes, Richard M Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F Li, Lien T Ngo, Andre Goy, Tatyana Feldman, David E Spaner, Michael L Wang, Clara C Chen, Sarah M Kranick, Avindra Nath, Debbie-Ann N Nathan, Kathleen E Morton, Mary Ann Toomey, Steven A Rosenberg |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 46% |
| India | 2 | 5% |
| United Kingdom | 1 | 3% |
| Russia | 1 | 3% |
| Belgium | 1 | 3% |
| Spain | 1 | 3% |
| Comoros | 1 | 3% |
| Japan | 1 | 3% |
| Unknown | 13 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 54% |
| Scientists | 11 | 28% |
| Practitioners (doctors, other healthcare professionals) | 5 | 13% |
| Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | <1% |
| United Kingdom | 2 | <1% |
| Brazil | 1 | <1% |
| Portugal | 1 | <1% |
| Canada | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Unknown | 1126 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 180 | 16% |
| Student > Bachelor | 159 | 14% |
| Student > Ph. D. Student | 153 | 13% |
| Student > Master | 109 | 10% |
| Other | 93 | 8% |
| Other | 193 | 17% |
| Unknown | 252 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 288 | 25% |
| Biochemistry, Genetics and Molecular Biology | 178 | 16% |
| Agricultural and Biological Sciences | 137 | 12% |
| Immunology and Microbiology | 116 | 10% |
| Engineering | 48 | 4% |
| Other | 111 | 10% |
| Unknown | 261 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 112. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#379,436
of 25,837,817 outputs
Outputs from Journal of Clinical Oncology
#710
of 22,362 outputs
Outputs of similar age
#3,338
of 248,866 outputs
Outputs of similar age from Journal of Clinical Oncology
#8
of 253 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,362 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,866 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.